Hematologist/Oncologist Physician
Prime Healthcare - Chicago, IL
Apply NowJob Description
Hematologist/Oncologist OpportunityPrime Healthcare Illinois Medical GroupAffiliated with St. Mary of Nazareth Hospital - Chicago, ILJoin a dynamic, community-focused oncology practice in the heart of Chicago as a BC/BE Hematologist/Oncologist. St. Mary of Nazareth Hospital, a 361-bed cornerstone of care in the Ukrainian Village neighborhood (on the near northwest side, just 2-3 miles west of downtown Chicago's Loop), delivers compassionate, high-quality services—including robust cancer treatment programs—to a diverse urban population.Why This Opportunity Stands Out:Employed position with Prime Illinois Medical Group (multi-specialty, hospital-affiliated)Full-time clinical role with strong referral base from primary care, specialists, and emergency servicesMix of solid tumors and hematologic malignancies; opportunity for benign hematology consultsModern outpatient oncology clinic with infusion center supportAccess to multidisciplinary team: radiology, pathology, surgery, radiation oncology (as needed), palliative careEMR: EpicHospital highlights: High Performing in key conditions (U.S. News & World Report 2025-2026), comprehensive services including cardiology, orthopedics, behavioral healthChicago offers world-class culture, dining, arts, Lake Michigan access, and excellent schools—all while making a real difference in a safety-net community hospital settingCompensation & Benefits Package (Competitive for Chicago Market):Base salary $450,000-$550,000+ (three-year guarantee)Productivity incentives / RVU-based bonusesSign-on bonus + relocation assistanceComprehensive benefits: health, dental, vision, malpractice (with tail), CME allowance, 401(k) match, paid time offProvide comprehensive inpatient and outpatient care for patients with solid tumors and hematologic malignancies (leukemia, lymphoma, myeloma, etc.)Manage benign hematology consults and non-malignant blood disorders as neededDevelop and oversee individualized treatment plans, including systemic therapies (chemotherapy, immunotherapy, targeted agents)Collaborate with multidisciplinary team (radiology, pathology, surgery, radiation oncology, palliative care) for optimal patient outcomesParticipate in tumor board discussions and quality initiativesDeliver patient-centered care with strong emphasis on communication, shared decision-making, and supportive servicesBoard-certified/eligible in Hematology and Medical Oncology (dual-boarded preferred)Fellowship-trained from an accredited programEligible for Illinois medical licenseStrong clinical skills, patient-centered approach, team playerPrime Healthcare Illinois Medical Group offers competitive compensation and a comprehensive benefits package that provides employees the flexibility to tailor benefits according to their individual needs. Our Total Rewards package includes, but is not limited to, paid time off, a 401K retirement plan, medical, dental, and vision coverage, tuition reimbursement, and many more voluntary benefit options. A reasonable compensation estimate for this role, which includes estimated wages, benefits, and other forms of compensation, is $450,000 -$550,000 on an annualized basis. The exact starting compensation to be offered will be determined at the time of selecting an applicant for hire, in which a wide range of factors will be considered, including but not limited to, skillset, years of applicable experience, education, credentials and licensure.Full TimeDaysCompany is an equal employment opportunity employer. Company prohibits discrimination against any applicant or employee based on race, color, sex, sexual orientation, gender identity, religion, national origin, age (subject to applicable law), disability, military status, genetic information or any other basis protected by applicable federal, state, or local laws. The Company also prohibits harassment of applicants or employees based on any of these protected categories. Know Your Rights:https://www.eeoc.gov/sites/default/files/2022-10/EEOC_KnowYourRights_screen_reader_10_20.pdf
Created: 2026-02-23